Heavy-chain diseases

Hematol Oncol Clin North Am. 1999 Dec;13(6):1281-94. doi: 10.1016/s0889-8588(05)70127-1.

Abstract

This review underscores the diversity of the structural and genetic abnormalities of HCD proteins and of the clinicopathologic features of the underlying lymphoproliferative disorders. Cells producing HCD may, however, all derive from a common normal precursor, which could be a rare B cell in the process of immunoglobulin gene somatic mutation within the germinal center.

Publication types

  • Review

MeSH terms

  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology
  • Heavy Chain Disease* / diagnosis
  • Heavy Chain Disease* / immunology
  • Heavy Chain Disease* / pathology
  • Heavy Chain Disease* / therapy
  • Humans
  • Immunoglobulin Heavy Chains / chemistry
  • Immunoglobulin Heavy Chains / genetics

Substances

  • Immunoglobulin Heavy Chains